novo nordisk glp 1 drug asks FDA to prevent compounders from making GLP-1 knockoffs Weight loss drugs don't work

eLife 11 , e80499 (2022)

McGowan B, Ciudin A, Baker JL, Busetto L, Dicker D, Frhbeck G, et al

Teresa Chioccarelli, Second University of Naples, Italy Copyright 2014 Guerriero, Trocchia, Abdel-Gawad and Ciarcia

Suspensions were centrifuged at 5,000 g for 5 min at 4C, supernatants were transferred to a new tube, and TCA buffer was added to a final concentration of 33% and incubated at 4C overnight to precipitate histone proteins

51 Similarly, another meta-analysis demonstrated that patients with T2DM receiving higher doses of tirzepatide exhibited a greater risk of GI adverse events compared to those receiving lower doses, consistent with a clear doseresponse relationship

Arslan S, Akdevelioglu Y